Represented LINTEC Corporation in its $375 million acquisition of MACtac Americas LLC from Platinum Equity.

Represented Marubeni Corporation in its acquisition of Creekstone Farms Premium Beef, LLC.

Represented Nitto Denko Corporation in various transactions, including:

• its acquisition of Avecia Biotechnology, Inc.;
• its acquisition of Altea Therapeutics Corporation;
• the sale of Aveva Drug Systems Inc. to Apotex Inc.;
• its strategic investment in Cosemi Technologies Inc.;
• its acquisition of Girindus America, Inc.;
• its acquisition of Irvine Pharmaceutical Services, Inc., and Avrio Biopharmaceuticals, LLC;
• its acquisition of nolax Airbag AG from nolax Holding AG; and
• its agreement granting Bristol-Myers Squibb Company exclusive worldwide rights for the development and commercialization of Nitto’s investigational siRNA molecules for an upfront payment of $100 million to Nitto with the rights to receive subsequent clinical and regulatory milestone payments, royalties, and sales-based milestone payments, as well as option exercise payments.

Represented NTT DOCOMO, INC. in various transactions, including:

• its going private transaction pursuant to a $40 billion tender offer by its parent company Nippon Telegraph, and Telephone Corporation, the largest-ever tender offer for a Japanese company (winner of the ALB Japan Law Awards 2021 "Technology, Media and Telecommunications Deal of the Year");
• its $280 million investment in Magic Leap, Inc., as part of a strategic partnership between the two companies;
• its acquisition of a 26 percent stake in Tata Teleservices Limited via a $2.7 billion strategic investment. This deal was awarded as a “Deal of the Year” by India Business Journal and by Asian-Counsel magazine; and
• the public auction of AT&T Wireless Services, Inc. (16 percent of which was owned by NTT DoCoMo) won by Cingular Wireless LLC for $41 billion.

Represented Otsuka Pharmaceutical Co., Ltd., in various transactions, including:

• its $3.5 billion acquisition of Avanir Pharmaceuticals, Inc.;
• its $886 million acquisition of Astex Pharmaceuticals, Inc.; and
• its acquisition of Neurovance, Inc., for $100 million in upfront payments at closing, up to $150 million in additional payments contingent on achievement of development and approval milestones, and future additional payments contingent on achievement of sales milestones.

Represented Shimizu Corporation in its U.S. investments, including its $147 million acquisition of the Albano Building, a high-rise office tower in Manhattan from the Vanbarton Group.

Represented Sumitomo Mitsui Banking Corporation in its acquisition of Flagship Rail Services LLC with the transaction value at $1.1 billion.

Represented the owner and chef of “Sushi of Gari,” the top-notch Manhattan restaurant chain, in its sale to a Japanese company.

Represented Toray Industries, Inc., in its $584 million acquisition of Zoltek Companies, Inc.

Represented Toshiba Corporation in various transactions, including:

• its $5.4 billion acquisition of Westinghouse Electric Company;
• its $1.2 billion sale of a 23 percent stake in Westinghouse acquisition vehicles to two strategic partners: The Shaw Group Inc. and IHI Corporation;
• its $540 million sale of a 10 percent stake in Westinghouse acquisition vehicles to National Atomic Company Kazatomprom, a supplier of uranium based in Kazakhstan; and
• its $1.6 billion acquisition of an additional 20 percent stake in Westinghouse acquisition vehicle from Nuclear Energy Holdings LLC, a subsidiary of the Shaw Group Inc.

Represented Toyota Industries Corporation in its $2 billion acquisition of the commercial finance business of Toyota Motor Credit Corporation.

Represented Zeon Corporation in its acquisition of Edge Precision Manufacturing, Inc.